← All trials
NCT04153760
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 336
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of CalgaryLead sponsor
- University of OttawaOverall official - principal investigator
- University of CalgaryOverall official - principal investigator
- Canadian Institutes of Health Research (CIHR)Collaborator
- Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) NetworkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.